Frontlight ResearchEarly access
Trial site
LEPL The First University Clinic of Tbilisi State Medical University
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Asthma1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- COPD1 trial
- Crohn's disease1 trial
- Myeloproliferative neoplasms1 trial
- Systemic sclerosis (scleroderma)1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting5 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Bambusa Therapeutics1 trial
- Boehringer Ingelheim1 trial
- Cinclus Pharma Holding AB1 trial
- Kartos Therapeutics, Inc.1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
- and 2 more
Running trials
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- COPD1 recruiting
- Crohn's disease1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026